Acquired resistance of a mammalian cell line to hypoxia-reoxygenation through cotransfection of Kir6.2 and SUR1 clones

Laboratory Investigation

Volumn 78, Issue 9, 1998, Pages 1101-1107

  Jovanovic, Aleksandar ^a   Jovanovic, Sofija ^a   Carrasco, Antonio J ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; POTASSIUM CHANNEL; POTASSIUM ION;

ANIMAL CELL; ARTICLE; GENETIC TRANSFECTION; HYPOXIA; ISCHEMIA; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; TISSUE INJURY;

ANIMALS; ANOXIA; CALCIUM; COS CELLS; GENETIC PREDISPOSITION TO DISEASE; GLYBURIDE; INTRACELLULAR MEMBRANES; MEMBRANE PROTEINS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; REPERFUSION INJURY; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSFECTION;

EID: 0031704523     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP, Boyd AE, Gonzales G, Hererra-Sosa H, Nguy K, Bryan J, and Nelson DA (1995). Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 268:423-426.
2. ATP channels. Physiol Rev 78: 227-245.
3. + channel behavior. J Membr Biol 159:161-168.
4. 2+ and pH. J Physiol 485:283-296.
5. Anderson WF (1998). Human gene therapy. Nature 392:25-30.
6. Brady PA and Terzic A (1998). The sulfonylurea controversy - more questions from the heart. J Am Coll Cardiol 31: 950-956.
7. 2+ loading in cardiomyocytes. Eur J Pharmacol 308:343-349.
8. Braunwald E (1997). Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med 337:1360-1369.
9. Carmeliet P and Collen D (1998). Molecular analysis of blood vessel formation and disease. Am J Physiol 42:H2091-H2104.
10. Chien KR (1993). Molecular advances in cardiovascular biology. Science 260:916-917.
11. Crystal RG (1995). Transfer of genes to humans: Early lessons and obstacles to success. Science 1270:404-410.
12. Gibbons GH and Dzau VJ (1996). Molecular therapies for vascular diseases. Science 272:689-693.
13. Granger DN and Korthius RJ (1995). Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 57:311-332.
14. Gross GJ (1995). ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol 90:85-88.
15. Gross GJ and Auchampach JA (1992). Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70:223-233.
16. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 75:309-315.
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
18. Hearse DJ (1995). Activation of ATP-sensitive potassium channels: A novel pharmacological approach to myocardial protection. Cardiovasc Res 30:1-17.
19. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 92:4666-4670.
20. KATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166-1170.
21. Jovanovic A, Alekseev AE, Lopez JR, Shen WK, and Terzic A (1997a). Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: Relevance for cardioplegia. Ann Thorac Surg 63:153-161.
22. + channel. Biochem Pharmacol 54:219-225.
23. 5-pentaphosphate harbors the properties of a signaling molecule in the heart. FEBS Lett 423:314-318.
24. 2+ loading: Insight into cardioprotection during cardioplegia. Ann Thorac Surg 65:586-591.
25. 2+ domain-dependent protective action of adenosine in a cardiomyocytes. Eur J Pharmacol 298:63-69.
26. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, and Anversa P (1996). Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74:86-107.
27. Kloner RA (1993). Does reperfusion injury exists in humans? J Am Coll Cardiol 21:537-545.
28. Koh GY, Kim SJ, Klug MG, Park K, Soonpaa MH, and Field LJ (1995). Targeted expression of transforming growth factor-β1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest 95:114-121.
29. 2+ activation of contraction as a consequence of reperfusion injury induced cellular calcium overload in ferret hearts. J Clin Invest 79:950-961.
30. Lauritzen I, De Weille JR, and Lazdunski M (1997). The potassium channel opener (-)-cromakalim prevents glutamate-induced cell death in hippocampal neurons. J Neurochem 69:1570-1579.
31. Leor J, Quinones MJ, Patterson M, Kedes L, and Kloner RA (1996). Adenovirus-mediated gene transfer into infarcted myocardium: Feasibility, timing, and location of expression. J Mol Cell Cardiol 28:2057-2067.
32. 2+ waves: A laser confocal microscopy study. Am J Physiol 270:H1384-H1389.
33. Lopez JR, Jahangir R, Jahangir A, Shen WK, and Terzic A (1996b). Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: Possible implications in cardioplegia. J Thorac Cardiovasc Surg 112:820-831.
34. Lopez JR, Jovanovic A, and Terzic A (1995). Spontaneous calcium waves without contraction in cardiac myocytes. Biochem Biophys Res Commun 214:781-787.
35. + channel. Mol Cell Biol 18:1652-1659.
36. Malosky S and Kolansky DM (1996). Gene therapy for ischemic heart disease. Curr Opin Cardiol 11:361-368.
37. Matsumoto T, Ikeda K, Mukaida N, Harada A, Matsumoto Y, Yamashita J, and Matsushima K (1997). Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 77:119-125.
38. ATP channel. Proc Natl Acad Sci USA 94:11969-11973.
39. Nabel EG (1995). Gene therapy for cardiovascular diseases. Circulation 91:541-548.
40. Paller MS (1994). The cell biology of reperfusion injury in the kidney. J Invest Med 42:632-639.
41. Sawa Y (1998). Gene therapy in cardiovascular surgery. Jpn J Surg 28:125-128.
42. Schwarz ER, Whyte WS, and Kloner RA (1997). Ischemic preconditioning. Curr Opin Cardiol 12:475-481.
43. Takeshita S, Tsurumi Y, Couffinahl T, Asahara T, Bauters C, Symes J, Ferrara N, and Isner JM (1996). Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 75:487-501.
44. + channel opening drugs. Am J Physiol 269:C525-C545, 1995.
45. Trost SU, Omens JH, Karlon WJ, Meyer M, Mestril R, Covell JW, and Dillman WH (1998). Protection against myocardial dysfunction after a brief ischemic preconditioning in transgenic mice expressing inducible heat shock protein 70. J Clin Invest 101:855-862.
46. Williams RS, Thomas JA, Fina M, German Z, and Benjamin IJ (1993). Human heat shock protein 70 (hsp70) protects murine cells from injury during metabolic stress. J Clin Invest 92: 503-508.